1. Pink Sheet
  2. >>Market Access

HHS Secretary Nominee Becerra Plans ‘Swift’ Action On Drug Pricing Reform

 
• By Cathy Kelly

‘We need the pharmaceutical industry … to always feel we’ve got their back to innovate,’ Becerra tells Senate Committee. ‘But we have to ensure that we’re getting our dollars’ worth.’

Xavier Becerra testifies before the HELP confirmation hearing on 23 February 2021. (screenshot)
Xavier Becerra told the HELP Committee confirmation hearing on 23 February 2021 • Source: Screenshot

US Health and Human Services Department Secretary-nominee Xavier Becerra will move quickly on policies to lower drug prices if confirmed, he told the Senate Health, Education, Labor and Pensions Committee during a hearing on his nomination 23 February.

The session served as a “courtesy” hearing because the HELP panel is not the committee of jurisdiction for voting on the nomination. That will be handled by the Finance Committee, which has a hearing on Becerra’s nomination scheduled for 24 February

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access